Λαμοτριγίνη (Greek Wikipedia)

Analysis of information sources in references of the Wikipedia article "Λαμοτριγίνη" in Greek language version.

refsWebsite

Global rank Greek rank

62nih.gov

4^th place

44doi.org

2^nd place

3^rd place

10archive.org

6^th place

5^th place

8web.archive.org

1^st place

4worldcat.org

5^th place

8^th place

3drugs.com

399^th place

130^th place

3fda.gov

447^th place

368^th place

2clincalc.com

3,912^th place

594^th place

2psychiatryonline.com

low place

2zenodo.org

621^st place

1,469^th place

2rxlist.com

7,927^th place

3,123^rd place

1psychiatrictimes.com

9,815^th place

7,251^st place

1books.google.com

3^rd place

6^th place

1neurology.org

9,919^th place

low place

1uni-muenchen.de

3,337^th place

4,693^rd place

1gsk.com

low place

1richmondpharmacology.com

low place

1tga.gov.au

3,984^th place

2,133^rd place

1gsk-clinicalstudyregister.com

low place

archive.org

Current Medical Diagnosis and Treatment, 45th ed. McGraw-Hill. 2006. ISBN 978-0071454100.
«Lamotrigine in psychiatric disorders». The Journal of Clinical Psychiatry 74 (7): 675–84. July 2013. doi:10.4088/JCP.12r08046. PMID 23945444. https://archive.org/details/sim_journal-of-clinical-psychiatry_2013-07_74_7/page/675.
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects Αρχειοθετήθηκε 2017-08-09 στο Wayback Machine.«Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects». British Journal of Clinical Pharmacology 66 (3): 396–404. September 2008. doi:10.1111/j.1365-2125.2008.03250.x. PMID 18662287. PMC 2526242. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2008-09_66_3/page/396.
Medications and Mothers' Milk (13th έκδοση). Hale Publishing. 2008. σελ. 532. ISBN 978-0-9815257-2-3.
«Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine». Clinical Neurophysiology 112 (6): 1018–22. June 2001. doi:10.1016/S1388-2457(01)00537-5. PMID 11377260. https://archive.org/details/sim_clinical-neurophysiology_2001-06_112_6/page/1018.
«Lamotrigine associated with insomnia». Epilepsia 40 (3): 322–5. March 1999. doi:10.1111/j.1528-1157.1999.tb00712.x. PMID 10080513. https://archive.org/details/sim_epilepsia_1999-03_40_3/page/322.
«Chapter 1: Principles of antiepileptic drug action». Antiepileptic Drugs, Fifth Edition. Lippincott Williams & Wilkins. 2002. σελίδες 3–22. ISBN 9780781723213.
«Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders». Neuropharmacology 42 (4): 522–9. March 2002. doi:10.1016/s0028-3908(01)00198-8. PMID 11955522. https://archive.org/details/sim_neuropharmacology_2002-03_42_4/page/522.
«Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans». Clinical Pharmacology and Therapeutics 42 (5): 535–41. November 1987. doi:10.1038/clpt.1987.193. PMID 3677542. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1987-11_42_5/page/535.
«A mechanistic approach to antiepileptic drug interactions». The Annals of Pharmacotherapy 32 (5): 554–63. May 1998. doi:10.1345/aph.17332. PMID 9606477. https://archive.org/details/sim_annals-of-pharmacotherapy_1998-05_32_5/page/554.

books.google.com

The Treatment of Epilepsy (4th έκδοση). John Wiley & Sons, Incorporated. 2015. σελ. 1321. ISBN 9781118936993.

clincalc.com

«The Top 300 of 2020». ClinCalc. Ανακτήθηκε στις 11 Απριλίου 2020.
«Lamotrigine - Drug Usage Statistics». ClinCalc. 23 Δεκεμβρίου 2019. Ανακτήθηκε στις 11 Απριλίου 2020.

doi.org

dx.doi.org

Bresnahan, Rebecca; Panebianco, Mariangela; Marson, Anthony G. (1 July 2020). «Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures». The Cochrane Database of Systematic Reviews 7: CD007783. doi:10.1002/14651858.CD007783.pub3. ISSN 1469-493X. PMID 32609387.
Panebianco, Mariangela; Bresnahan, Rebecca; Ramaratnam, Sridharan; Marson, Anthony G. (20 March 2020). «Lamotrigine add-on therapy for drug-resistant focal epilepsy». The Cochrane Database of Systematic Reviews 3: CD001909. doi:10.1002/14651858.CD001909.pub3. ISSN 1469-493X. PMID 32196639.
«Treatment of Lennox-Gastaut syndrome». The Cochrane Database of Systematic Reviews (2): CD003277. February 2013. doi:10.1002/14651858.CD003277.pub3. PMID 23450537.
«Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society». Neurology 62 (8): 1261–73. April 2004. doi:10.1212/01.WNL.0000123695.22623.32. PMID 15111660. Αρχειοθετήθηκε από το πρωτότυπο στις 2004-12-16. https://web.archive.org/web/20041216010053/http://www.neurology.org/cgi/content/full/62/8/1261. Ανακτήθηκε στις 2020-10-09.
«Managing pediatric epilepsy syndromes with new antiepileptic drugs». Pediatrics 104 (5 Pt 1): 1106–16. November 1999. doi:10.1542/peds.104.5.1106. PMID 10545555.
«Lamotrigine: a review of its use in bipolar disorder». Drugs 63 (19): 2029–50. 2003. doi:10.2165/00003495-200363190-00009. PMID 12962521.
«Treatment of bipolar disorder». Lancet 381 (9878): 1672–82. May 2013. doi:10.1016/S0140-6736(13)60857-0. PMID 23663953.
«Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials». Bipolar Disorders 10 (2): 323–33. March 2008. doi:10.1111/j.1399-5618.2007.00500.x. PMID 18271912.
«Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials». The British Journal of Psychiatry 194 (1): 4–9. January 2009. doi:10.1192/bjp.bp.107.048504. PMID 19118318.
«Lamotrigine in psychiatric disorders». The Journal of Clinical Psychiatry 74 (7): 675–84. July 2013. doi:10.4088/JCP.12r08046. PMID 23945444. https://archive.org/details/sim_journal-of-clinical-psychiatry_2013-07_74_7/page/675.
«Neuromodulating drugs for the symptomatic treatment of neuropathic pain». Current Pain and Headache Reports 8 (3): 212–6. June 2004. doi:10.1007/s11916-004-0054-4. PMID 15115640.
«Anticonvulsants in neuropathic pain: rationale and clinical evidence». European Journal of Pain 6 Suppl A: 61–8. 2002. doi:10.1053/eujp.2001.0324. PMID 11888243.
«Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine». Clinical Therapeutics 25 (10): 2506–38. October 2003. doi:10.1016/S0149-2918(03)80314-4. PMID 14667954.
Bou Ghannam, Alaa; Pelak, Victoria S. (March 2017). «Visual Snow: a Potential Cortical Hyperexcitability Syndrome». Current Treatment Options in Neurology 19 (3): 9. doi:10.1007/s11940-017-0448-3. ISSN 1092-8480. PMID 28349350.
«Lamotrigine for chronic neuropathic pain and fibromyalgia in adults». The Cochrane Database of Systematic Reviews (12): CD006044. December 2013. doi:10.1002/14651858.CD006044.pub4. PMID 24297457.
«Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia». Indian Journal of Psychological Medicine 37 (2): 154–8. 2015. doi:10.4103/0253-7176.155613. PMID 25969599.
Medford, N. (2005). «Understanding and treating depersonalisation disorder». Advances in Psychiatric Treatment 11 (2): 92–100. doi:10.1192/apt.11.2.92.
«Hallucinogen-persisting perception disorder». Therapeutic Advances in Psychopharmacology 2 (5): 199–205. October 2012. doi:10.1177/2045125312451270. PMID 23983976.
«Lamotrigine in the treatment of schizoaffective disorder». Neuropsychobiology 38 (3): 204–5. October 1998. doi:10.1159/000026540. PMID 9778612. https://epub.ub.uni-muenchen.de/16560/1/10_1159_000026540.pdf.
«Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials». The British Journal of Psychiatry 196 (1): 4–12. January 2010. doi:10.1192/bjp.bp.108.062984. PMID 20044651.
Stein, D. J.; Ipser, J. C.; Seedat, S. (2006-01-25). «Pharmacotherapy for post traumatic stress disorder (PTSD)». The Cochrane Database of Systematic Reviews (1): CD002795. doi:10.1002/14651858.CD002795.pub2. ISSN 1469-493X. PMID 16437445.
«Lamotrigine rechallenge after a skin rash. A combined study of open cases and a meta-analysis». Revista de Psiquiatria y Salud Mental 6 (4): 144–9. Jun 2012. doi:10.1016/j.rpsm.2012.04.002. PMID 23084805. https://zenodo.org/record/895436.
«Leucopenia associated with lamotrigine». BMJ (Clinical Research Ed.) 310 (6978): 504. February 1995. doi:10.1136/bmj.310.6978.504b. PMID 7888892.
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects Αρχειοθετήθηκε 2017-08-09 στο Wayback Machine.«Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects». British Journal of Clinical Pharmacology 66 (3): 396–404. September 2008. doi:10.1111/j.1365-2125.2008.03250.x. PMID 18662287. PMC 2526242. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2008-09_66_3/page/396.
«Lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report». The Journal of Neuropsychiatry and Clinical Neurosciences 24 (2): E38–9. March 2012. doi:10.1176/appi.neuropsych.11040093. PMID 22772697.
«Neuroleptic malignant syndrome induced by lamotrigine». Clinical Neuropharmacology 36 (4): 131–2. July–August 2013. doi:10.1097/WNF.0b013e318294799a. PMID 23783003.
«Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations». Epilepsia 46 (9): 1414–7. September 2005. doi:10.1111/j.1528-1167.2005.10105.x. PMID 16146436.
«Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case series». Journal of Psychopharmacology 28 (3): 282–3. March 2014. doi:10.1177/0269881113493365. PMID 23784736.
«The effects of lamotrigine on sleep in patients with epilepsy». Epilepsia 42 (12): 1569–73. December 2001. doi:10.1046/j.1528-1157.2001.46100.x. PMID 11879368.
«Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine». Clinical Neurophysiology 112 (6): 1018–22. June 2001. doi:10.1016/S1388-2457(01)00537-5. PMID 11377260. https://archive.org/details/sim_clinical-neurophysiology_2001-06_112_6/page/1018.
«Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy». Acta Neurologica Scandinavica 102 (2): 81–6. August 2000. doi:10.1034/j.1600-0404.2000.102002081.x. PMID 10949523.
«Lamotrigine associated with insomnia». Epilepsia 40 (3): 322–5. March 1999. doi:10.1111/j.1528-1157.1999.tb00712.x. PMID 10080513. https://archive.org/details/sim_epilepsia_1999-03_40_3/page/322.
«The neurobiology of antiepileptic drugs». Nature Reviews. Neuroscience 5 (7): 553–64. July 2004. doi:10.1038/nrn1430. PMID 15208697. https://zenodo.org/record/1233562.
«Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex». Brain Research 612 (1–2): 190–9. May 1993. doi:10.1016/0006-8993(93)91660-K. PMID 7687190.
«Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)». Journal of Mental Health 19 (2): 168–75. April 2010. doi:10.3109/09638230903469269. PMID 20433324.
«Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders». Journal of Clinical Psychopharmacology 23 (5): 484–95. October 2003. doi:10.1097/01.jcp.0000088915.02635.e8. PMID 14520126.
«Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders». Neuropharmacology 42 (4): 522–9. March 2002. doi:10.1016/s0028-3908(01)00198-8. PMID 11955522. https://archive.org/details/sim_neuropharmacology_2002-03_42_4/page/522.
«Effect of lamotrigine on plasma GABA levels in healthy humans». Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 (3): 419–23. May 2003. doi:10.1016/S0278-5846(03)00028-9. PMID 12691776.
«Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats». European Journal of Pharmacology 358 (1): 19–24. September 1998. doi:10.1016/s0014-2999(98)00580-9. PMID 9809864.
«Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy». Epilepsy Research 10 (2–3): 191–200. 1991. doi:10.1016/0920-1211(91)90012-5. PMID 1817959.
«Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans». Clinical Pharmacology and Therapeutics 42 (5): 535–41. November 1987. doi:10.1038/clpt.1987.193. PMID 3677542. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1987-11_42_5/page/535.
«Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release». Therapeutics and Clinical Risk Management 4 (5): 1035–46. October 2008. doi:10.2147/TCRM.S3343. PMID 19209284.
«Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy». Drugs 46 (1): 152–76. July 1993. doi:10.2165/00003495-199346010-00009. PMID 7691504.
«A mechanistic approach to antiepileptic drug interactions». The Annals of Pharmacotherapy 32 (5): 554–63. May 1998. doi:10.1345/aph.17332. PMID 9606477. https://archive.org/details/sim_annals-of-pharmacotherapy_1998-05_32_5/page/554.

drugs.com

«Lamotrigine Use During Pregnancy». Drugs.com. 8 Οκτωβρίου 2019. Ανακτήθηκε στις 24 Μαρτίου 2020.
«Lamotrigine». Drugs.com. Ανακτήθηκε στις 9 Δεκεμβρίου 2017.
«Lamotrigine». The American Society of Health-System Pharmacists. Ανακτήθηκε στις 8 Δεκεμβρίου 2017.

fda.gov

GlaxoSmithKline (12 Οκτωβρίου 2010). «Lamictal (lamotrigine) Label Information» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 20 Απριλίου 2017. Ανακτήθηκε στις 5 Αυγούστου 2019.
«Safety Alerts for Human Medical Products - Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction». www.fda.gov. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Ιουλίου 2018. Ανακτήθηκε στις 14 Μαΐου 2018.

accessdata.fda.gov

«Prescribing Information for LAMICTAL (lamotrigine)» (PDF). FDA.

gsk-clinicalstudyregister.com

Glaxo Smith Klein Clinical Study Register, Study No. LAM40120: Lamotrigine (Lamictal) Treatment in adults with Attention Deficit Hyperactivity Disorder (ADHD), A pilot study Αρχειοθετήθηκε 2017-12-01 στο Wayback Machine.

gsk.com

us.gsk.com

«Lamictal Prescribing Information» (PDF). GlaxoSmithKline. Μαΐου 2007. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 13 Σεπτεμβρίου 2006. Ανακτήθηκε στις 9 Απριλίου 2008.

neurology.org

«Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society». Neurology 62 (8): 1261–73. April 2004. doi:10.1212/01.WNL.0000123695.22623.32. PMID 15111660. Αρχειοθετήθηκε από το πρωτότυπο στις 2004-12-16. https://web.archive.org/web/20041216010053/http://www.neurology.org/cgi/content/full/62/8/1261. Ανακτήθηκε στις 2020-10-09.

nih.gov

ncbi.nlm.nih.gov

Bresnahan, Rebecca; Panebianco, Mariangela; Marson, Anthony G. (1 July 2020). «Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures». The Cochrane Database of Systematic Reviews 7: CD007783. doi:10.1002/14651858.CD007783.pub3. ISSN 1469-493X. PMID 32609387.
Panebianco, Mariangela; Bresnahan, Rebecca; Ramaratnam, Sridharan; Marson, Anthony G. (20 March 2020). «Lamotrigine add-on therapy for drug-resistant focal epilepsy». The Cochrane Database of Systematic Reviews 3: CD001909. doi:10.1002/14651858.CD001909.pub3. ISSN 1469-493X. PMID 32196639.
«Treatment of Lennox-Gastaut syndrome». The Cochrane Database of Systematic Reviews (2): CD003277. February 2013. doi:10.1002/14651858.CD003277.pub3. PMID 23450537.
«Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society». Neurology 62 (8): 1261–73. April 2004. doi:10.1212/01.WNL.0000123695.22623.32. PMID 15111660. Αρχειοθετήθηκε από το πρωτότυπο στις 2004-12-16. https://web.archive.org/web/20041216010053/http://www.neurology.org/cgi/content/full/62/8/1261. Ανακτήθηκε στις 2020-10-09.
«Managing pediatric epilepsy syndromes with new antiepileptic drugs». Pediatrics 104 (5 Pt 1): 1106–16. November 1999. doi:10.1542/peds.104.5.1106. PMID 10545555.
«Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder». Medscape Journal of Medicine 10 (9): 211. 2008. PMID 19008973.
«Lamotrigine: a review of its use in bipolar disorder». Drugs 63 (19): 2029–50. 2003. doi:10.2165/00003495-200363190-00009. PMID 12962521.
«Treatment of bipolar disorder». Lancet 381 (9878): 1672–82. May 2013. doi:10.1016/S0140-6736(13)60857-0. PMID 23663953.
«Lamotrigine in the acute treatment of bipolar depression: results of five double-blind, placebo-controlled clinical trials». Bipolar Disorders 10 (2): 323–33. March 2008. doi:10.1111/j.1399-5618.2007.00500.x. PMID 18271912.
«Lamotrigine for treatment of bipolar depression: independent meta-analysis and meta-regression of individual patient data from five randomised trials». The British Journal of Psychiatry 194 (1): 4–9. January 2009. doi:10.1192/bjp.bp.107.048504. PMID 19118318.
«Lamotrigine in psychiatric disorders». The Journal of Clinical Psychiatry 74 (7): 675–84. July 2013. doi:10.4088/JCP.12r08046. PMID 23945444. https://archive.org/details/sim_journal-of-clinical-psychiatry_2013-07_74_7/page/675.
«Neuromodulating drugs for the symptomatic treatment of neuropathic pain». Current Pain and Headache Reports 8 (3): 212–6. June 2004. doi:10.1007/s11916-004-0054-4. PMID 15115640.
«Anticonvulsants in neuropathic pain: rationale and clinical evidence». European Journal of Pain 6 Suppl A: 61–8. 2002. doi:10.1053/eujp.2001.0324. PMID 11888243.
«Newer antiepileptic drugs: possible uses in the treatment of neuropathic pain and migraine». Clinical Therapeutics 25 (10): 2506–38. October 2003. doi:10.1016/S0149-2918(03)80314-4. PMID 14667954.
Bou Ghannam, Alaa; Pelak, Victoria S. (March 2017). «Visual Snow: a Potential Cortical Hyperexcitability Syndrome». Current Treatment Options in Neurology 19 (3): 9. doi:10.1007/s11940-017-0448-3. ISSN 1092-8480. PMID 28349350.
«Lamotrigine for chronic neuropathic pain and fibromyalgia in adults». The Cochrane Database of Systematic Reviews (12): CD006044. December 2013. doi:10.1002/14651858.CD006044.pub4. PMID 24297457.
«Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia». Indian Journal of Psychological Medicine 37 (2): 154–8. 2015. doi:10.4103/0253-7176.155613. PMID 25969599.
«Hallucinogen-persisting perception disorder». Therapeutic Advances in Psychopharmacology 2 (5): 199–205. October 2012. doi:10.1177/2045125312451270. PMID 23983976.
«Lamotrigine in the treatment of schizoaffective disorder». Neuropsychobiology 38 (3): 204–5. October 1998. doi:10.1159/000026540. PMID 9778612. https://epub.ub.uni-muenchen.de/16560/1/10_1159_000026540.pdf.
«Pharmacotherapy for borderline personality disorder: Cochrane systematic review of randomised trials». The British Journal of Psychiatry 196 (1): 4–12. January 2010. doi:10.1192/bjp.bp.108.062984. PMID 20044651.
Stein, D. J.; Ipser, J. C.; Seedat, S. (2006-01-25). «Pharmacotherapy for post traumatic stress disorder (PTSD)». The Cochrane Database of Systematic Reviews (1): CD002795. doi:10.1002/14651858.CD002795.pub2. ISSN 1469-493X. PMID 16437445.
«Lamotrigine rechallenge after a skin rash. A combined study of open cases and a meta-analysis». Revista de Psiquiatria y Salud Mental 6 (4): 144–9. Jun 2012. doi:10.1016/j.rpsm.2012.04.002. PMID 23084805. https://zenodo.org/record/895436.
«Leucopenia associated with lamotrigine». BMJ (Clinical Research Ed.) 310 (6978): 504. February 1995. doi:10.1136/bmj.310.6978.504b. PMID 7888892.
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects Αρχειοθετήθηκε 2017-08-09 στο Wayback Machine.«Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects». British Journal of Clinical Pharmacology 66 (3): 396–404. September 2008. doi:10.1111/j.1365-2125.2008.03250.x. PMID 18662287. PMC 2526242. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2008-09_66_3/page/396.
«Lamotrigine-induced neuroleptic malignant syndrome under risperidone treatment: a case report». The Journal of Neuropsychiatry and Clinical Neurosciences 24 (2): E38–9. March 2012. doi:10.1176/appi.neuropsych.11040093. PMID 22772697.
«Neuroleptic malignant syndrome induced by lamotrigine». Clinical Neuropharmacology 36 (4): 131–2. July–August 2013. doi:10.1097/WNF.0b013e318294799a. PMID 23783003.
«Ethinyl estradiol, not progestogens, reduces lamotrigine serum concentrations». Epilepsia 46 (9): 1414–7. September 2005. doi:10.1111/j.1528-1167.2005.10105.x. PMID 16146436.
«[Teratogenic effects of lamotrigine in women with bipolar disorder]» (στα Dutch). Tijdschrift voor Psychiatrie 51 (10): 741–50. 2009. PMID 19821242.
«Lamotrigine in pregnancy: safety profile and the risk of malformations». Singapore Medical Journal 48 (10): 880–3. October 2007. PMID 17909669.
«Lamotrigine for attention deficit-hyperactivity disorder comorbid with mood disorders: a case series». Journal of Psychopharmacology 28 (3): 282–3. March 2014. doi:10.1177/0269881113493365. PMID 23784736.
«The effects of lamotrigine on sleep in patients with epilepsy». Epilepsia 42 (12): 1569–73. December 2001. doi:10.1046/j.1528-1157.2001.46100.x. PMID 11879368.
«Neurophysiological evaluation of vigilance in epileptic patients on monotherapy with lamotrigine». Clinical Neurophysiology 112 (6): 1018–22. June 2001. doi:10.1016/S1388-2457(01)00537-5. PMID 11377260. https://archive.org/details/sim_clinical-neurophysiology_2001-06_112_6/page/1018.
«Effects of lamotrigine on nocturnal sleep, daytime somnolence and cognitive functions in focal epilepsy». Acta Neurologica Scandinavica 102 (2): 81–6. August 2000. doi:10.1034/j.1600-0404.2000.102002081.x. PMID 10949523.
«Lamotrigine associated with insomnia». Epilepsia 40 (3): 322–5. March 1999. doi:10.1111/j.1528-1157.1999.tb00712.x. PMID 10080513. https://archive.org/details/sim_epilepsia_1999-03_40_3/page/322.
«The neurobiology of antiepileptic drugs». Nature Reviews. Neuroscience 5 (7): 553–64. July 2004. doi:10.1038/nrn1430. PMID 15208697. https://zenodo.org/record/1233562.
«Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex». Brain Research 612 (1–2): 190–9. May 1993. doi:10.1016/0006-8993(93)91660-K. PMID 7687190.
«Systematic review of lamotrigine augmentation of treatment resistant unipolar depression (TRD)». Journal of Mental Health 19 (2): 168–75. April 2010. doi:10.3109/09638230903469269. PMID 20433324.
«Potential mechanisms of action of lamotrigine in the treatment of bipolar disorders». Journal of Clinical Psychopharmacology 23 (5): 484–95. October 2003. doi:10.1097/01.jcp.0000088915.02635.e8. PMID 14520126.
«Lamotrigine reduces spontaneous and evoked GABAA receptor-mediated synaptic transmission in the basolateral amygdala: implications for its effects in seizure and affective disorders». Neuropharmacology 42 (4): 522–9. March 2002. doi:10.1016/s0028-3908(01)00198-8. PMID 11955522. https://archive.org/details/sim_neuropharmacology_2002-03_42_4/page/522.
«Effect of lamotrigine on plasma GABA levels in healthy humans». Progress in Neuro-Psychopharmacology & Biological Psychiatry 27 (3): 419–23. May 2003. doi:10.1016/S0278-5846(03)00028-9. PMID 12691776.
«Lamotrigine inhibits monoamine uptake in vitro and modulates 5-hydroxytryptamine uptake in rats». European Journal of Pharmacology 358 (1): 19–24. September 1998. doi:10.1016/s0014-2999(98)00580-9. PMID 9809864.
«Pharmacokinetics and safety of lamotrigine (Lamictal) in patients with epilepsy». Epilepsy Research 10 (2–3): 191–200. 1991. doi:10.1016/0920-1211(91)90012-5. PMID 1817959.
«Lamotrigine, a new anticonvulsant: pharmacokinetics in normal humans». Clinical Pharmacology and Therapeutics 42 (5): 535–41. November 1987. doi:10.1038/clpt.1987.193. PMID 3677542. https://archive.org/details/sim_clinical-pharmacology-and-therapeutics_1987-11_42_5/page/535.
«Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release». Therapeutics and Clinical Risk Management 4 (5): 1035–46. October 2008. doi:10.2147/TCRM.S3343. PMID 19209284.
«Lamotrigine. A review of its pharmacological properties and clinical efficacy in epilepsy». Drugs 46 (1): 152–76. July 1993. doi:10.2165/00003495-199346010-00009. PMID 7691504.
«A mechanistic approach to antiepileptic drug interactions». The Annals of Pharmacotherapy 32 (5): 554–63. May 1998. doi:10.1345/aph.17332. PMID 9606477. https://archive.org/details/sim_annals-of-pharmacotherapy_1998-05_32_5/page/554.

pubmedcentral.nih.gov

Panebianco, Mariangela; Bresnahan, Rebecca; Ramaratnam, Sridharan; Marson, Anthony G. (20 March 2020). «Lamotrigine add-on therapy for drug-resistant focal epilepsy». The Cochrane Database of Systematic Reviews 3: CD001909. doi:10.1002/14651858.CD001909.pub3. ISSN 1469-493X. PMID 32196639.
«Treatment of Lennox-Gastaut syndrome». The Cochrane Database of Systematic Reviews (2): CD003277. February 2013. doi:10.1002/14651858.CD003277.pub3. PMID 23450537.
«Publication bias and the pharmaceutical industry: the case of lamotrigine in bipolar disorder». Medscape Journal of Medicine 10 (9): 211. 2008. PMID 19008973.
«Treatment of bipolar disorder». Lancet 381 (9878): 1672–82. May 2013. doi:10.1016/S0140-6736(13)60857-0. PMID 23663953.
«Lamotrigine for chronic neuropathic pain and fibromyalgia in adults». The Cochrane Database of Systematic Reviews (12): CD006044. December 2013. doi:10.1002/14651858.CD006044.pub4. PMID 24297457.
«Role of lamotrigine augmentation in treatment-resistant obsessive compulsive disorder: a retrospective case review from South Asia». Indian Journal of Psychological Medicine 37 (2): 154–8. 2015. doi:10.4103/0253-7176.155613. PMID 25969599.
«Hallucinogen-persisting perception disorder». Therapeutic Advances in Psychopharmacology 2 (5): 199–205. October 2012. doi:10.1177/2045125312451270. PMID 23983976.
Stein, D. J.; Ipser, J. C.; Seedat, S. (2006-01-25). «Pharmacotherapy for post traumatic stress disorder (PTSD)». The Cochrane Database of Systematic Reviews (1): CD002795. doi:10.1002/14651858.CD002795.pub2. ISSN 1469-493X. PMID 16437445.
«Leucopenia associated with lamotrigine». BMJ (Clinical Research Ed.) 310 (6978): 504. February 1995. doi:10.1136/bmj.310.6978.504b. PMID 7888892.
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects Αρχειοθετήθηκε 2017-08-09 στο Wayback Machine.«Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects». British Journal of Clinical Pharmacology 66 (3): 396–404. September 2008. doi:10.1111/j.1365-2125.2008.03250.x. PMID 18662287. PMC 2526242. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2008-09_66_3/page/396.
«Pharmacotherapeutics of epilepsy: use of lamotrigine and expectations for lamotrigine extended release». Therapeutics and Clinical Risk Management 4 (5): 1035–46. October 2008. doi:10.2147/TCRM.S3343. PMID 19209284.

dailymed.nlm.nih.gov

«Drug Label Information». Dailymed. National Institute of Health. Ανακτήθηκε στις 8 Μαΐου 2014.
unknown, unknown. «Lamictal». National Institute of Health. Ανακτήθηκε στις 8 Μαΐου 2014.
«DailyMed - LAMOTRIGINE - lamotrigine chewable dispersible tablet, for suspension». DailyMed. U.S. National Library of Medicine. Ανακτήθηκε στις 23 Αυγούστου 2017.
«LAMICTAL (lamotrigine) tablet». Daily Med. U.S. National Library of Medicine. Ανακτήθηκε στις 26 Δεκεμβρίου 2013.

pubchem.ncbi.nlm.nih.gov

«Lamotrigine». PubChem Open Chemistry Database. US: National Institutes of Health. Ανακτήθηκε στις 13 Δεκεμβρίου 2016.

psychiatrictimes.com

«Lamotrigine: Its Role in Bipolar Disorder». PsychiatricTimes. Ανακτήθηκε στις 1 Σεπτεμβρίου 2020.

psychiatryonline.com

«Acute Treatment — Formula and Implementation of a Treatment Plan». Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition. American Psychiatric Association. Αρχειοθετήθηκε από το πρωτότυπο στις 30 Σεπτεμβρίου 2010. Ανακτήθηκε στις 15 Αυγούστου 2010.
«Main page». Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition. American Psychiatric Association. Ανακτήθηκε στις 15 Αυγούστου 2010.

richmondpharmacology.com

Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects Αρχειοθετήθηκε 2017-08-09 στο Wayback Machine.«Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects». British Journal of Clinical Pharmacology 66 (3): 396–404. September 2008. doi:10.1111/j.1365-2125.2008.03250.x. PMID 18662287. PMC 2526242. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2008-09_66_3/page/396.

rxlist.com

«Lamictal (Lamotrigine): Uses, Dosage, Side Effects, Interactions, Warning».
anonymous. «Lamictal, Warnings & Precautions». RxList Inc. Αρχειοθετήθηκε από το πρωτότυπο στις 29 Μαρτίου 2008. Ανακτήθηκε στις 9 Απριλίου 2008.

tga.gov.au

ebs.tga.gov.au

«Product Information Lamotrigine Sandoz 25mg, 50mg, 100mg, 200mg, Dispersible/Chewable Tablets». TGA eBusiness Services. Sandoz Pty Ltd. 10 Ιανουαρίου 2017. Ανακτήθηκε στις 23 Αυγούστου 2017.

uni-muenchen.de

epub.ub.uni-muenchen.de

«Lamotrigine in the treatment of schizoaffective disorder». Neuropsychobiology 38 (3): 204–5. October 1998. doi:10.1159/000026540. PMID 9778612. https://epub.ub.uni-muenchen.de/16560/1/10_1159_000026540.pdf.

web.archive.org

«Efficacy and tolerability of the new antiepileptic drugs II: treatment of refractory epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society». Neurology 62 (8): 1261–73. April 2004. doi:10.1212/01.WNL.0000123695.22623.32. PMID 15111660. Αρχειοθετήθηκε από το πρωτότυπο στις 2004-12-16. https://web.archive.org/web/20041216010053/http://www.neurology.org/cgi/content/full/62/8/1261. Ανακτήθηκε στις 2020-10-09.
GlaxoSmithKline (12 Οκτωβρίου 2010). «Lamictal (lamotrigine) Label Information» (PDF). Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 20 Απριλίου 2017. Ανακτήθηκε στις 5 Αυγούστου 2019.
«Acute Treatment — Formula and Implementation of a Treatment Plan». Practice Guideline for the Treatment of Patients With Bipolar Disorder Second Edition. American Psychiatric Association. Αρχειοθετήθηκε από το πρωτότυπο στις 30 Σεπτεμβρίου 2010. Ανακτήθηκε στις 15 Αυγούστου 2010.
«Lamictal Prescribing Information» (PDF). GlaxoSmithKline. Μαΐου 2007. Αρχειοθετήθηκε από το πρωτότυπο (PDF) στις 13 Σεπτεμβρίου 2006. Ανακτήθηκε στις 9 Απριλίου 2008.
Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects Αρχειοθετήθηκε 2017-08-09 στο Wayback Machine.«Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects». British Journal of Clinical Pharmacology 66 (3): 396–404. September 2008. doi:10.1111/j.1365-2125.2008.03250.x. PMID 18662287. PMC 2526242. https://archive.org/details/sim_british-journal-of-clinical-pharmacology_2008-09_66_3/page/396.
«Safety Alerts for Human Medical Products - Lamictal (lamotrigine): Drug Safety Communication - Serious Immune System Reaction». www.fda.gov. Αρχειοθετήθηκε από το πρωτότυπο στις 25 Ιουλίου 2018. Ανακτήθηκε στις 14 Μαΐου 2018.
anonymous. «Lamictal, Warnings & Precautions». RxList Inc. Αρχειοθετήθηκε από το πρωτότυπο στις 29 Μαρτίου 2008. Ανακτήθηκε στις 9 Απριλίου 2008.
Glaxo Smith Klein Clinical Study Register, Study No. LAM40120: Lamotrigine (Lamictal) Treatment in adults with Attention Deficit Hyperactivity Disorder (ADHD), A pilot study Αρχειοθετήθηκε 2017-12-01 στο Wayback Machine.

worldcat.org

Bresnahan, Rebecca; Panebianco, Mariangela; Marson, Anthony G. (1 July 2020). «Lamotrigine add-on therapy for drug-resistant generalised tonic-clonic seizures». The Cochrane Database of Systematic Reviews 7: CD007783. doi:10.1002/14651858.CD007783.pub3. ISSN 1469-493X. PMID 32609387.
Panebianco, Mariangela; Bresnahan, Rebecca; Ramaratnam, Sridharan; Marson, Anthony G. (20 March 2020). «Lamotrigine add-on therapy for drug-resistant focal epilepsy». The Cochrane Database of Systematic Reviews 3: CD001909. doi:10.1002/14651858.CD001909.pub3. ISSN 1469-493X. PMID 32196639.
Bou Ghannam, Alaa; Pelak, Victoria S. (March 2017). «Visual Snow: a Potential Cortical Hyperexcitability Syndrome». Current Treatment Options in Neurology 19 (3): 9. doi:10.1007/s11940-017-0448-3. ISSN 1092-8480. PMID 28349350.
Stein, D. J.; Ipser, J. C.; Seedat, S. (2006-01-25). «Pharmacotherapy for post traumatic stress disorder (PTSD)». The Cochrane Database of Systematic Reviews (1): CD002795. doi:10.1002/14651858.CD002795.pub2. ISSN 1469-493X. PMID 16437445.

zenodo.org

«Lamotrigine rechallenge after a skin rash. A combined study of open cases and a meta-analysis». Revista de Psiquiatria y Salud Mental 6 (4): 144–9. Jun 2012. doi:10.1016/j.rpsm.2012.04.002. PMID 23084805. https://zenodo.org/record/895436.
«The neurobiology of antiepileptic drugs». Nature Reviews. Neuroscience 5 (7): 553–64. July 2004. doi:10.1038/nrn1430. PMID 15208697. https://zenodo.org/record/1233562.